Peer-reviewedCC BY-NC-NDBlood vessels, thrombosis & hemostasis
Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
- 1Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
Related
- CIRCULATING INFLAMMATORY MEDIATORS REPROGRAM PLATELETS TOWARD A PRO-COAGULANT PHENOTYPE IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
- MicroRNA cargo of extracellular vesicles as mediators of immune dysregulation in pediatric immune thrombocytopenia: from pathogenetic drivers to biomarkers.
- Blood-Based Biomarkers in Alzheimer's Disease: Advances in Detection Technologies and Clinical Applications.
- Decoding Parkinson's disease: a systematic review of qEEG biomarkers across clinical domains
- Plasma neurofilament light links mortality to neuroaxonal injury beyond clinical decline and Alzheimer disease plasma biomarkers: a multi-cohort study of oldest old individuals
BibTeX
@article{alfred2026platelets,
title = {{Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials}},
author = {Joanne C. Alfred and Erica M. Sparkenbaugh},
journal = {Blood vessels, thrombosis \& hemostasis},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13675878},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
AU - Joanne C. Alfred
AU - Erica M. Sparkenbaugh
PY - 2026
DA - 2026/09/04
JO - Blood vessels, thrombosis & hemostasis
UR - https://europepmc.org/article/PMC/PMC13675878
SN - 2950-3272
ER -